IPHASE Imamaliza Kulembetsa Magazi a FDA Kuti Athandizire Kuchita Zabwino kwa Biopharma
IPHASE ndiyonyadira kulengeza kuti kumaliza bwino kwa Kulembetsa Magazi a FDA a chaka chino, kulimbitsa kudzipereka kwathu pakutsata malamulo, mtundu, ndi biopharma-ntchito zokonzeka.
Pansi pa malamulo a FDA (21 CFR 607), mabungwe opangidwa ndi magazi ndi magazi-zochokera kumagazi amayenera kulembetsa ku bungweli ndikulemba mndandanda wazinthu zomwe zikuyenera kugwiritsidwa ntchito. Kulembetsa kumeneku kumatsimikizira kuti malo athu amakwaniritsa zofunikira za FDA popanga ndi kusamalira magazi ndi zinthu zochokera kumagazi. Kwa othandizana nawo a biopharmaceutical, izi zimatanthawuza chidaliro mu mtundu, kutsatiridwa, ndi kulimba kwa zinthu za biomatrix zomwe zimathandizira kafukufuku wam'mbuyomu, kakulidwe ka mayeso, ndi kugwiritsa ntchito pansi.
Ku IPHASE, kutsata kumapangidwa mu gawo lililonse lanjira yathu. Timakhala odzipereka kuti tipereke mayankho osasinthika, odalirika, komanso apamwamba - apamwamba kwambiri a biomatrix omwe amathandizira magulu a biopharma kuyenda mwachangu-kuchokera pomwe atulukira kudzera pachitukuko pomwe akukumana ndi ziyembekezo zomwe zikusinthika.

Nthawi yotumiza: 2026 - 01 - 27 16:37:06

